Abstract:ABO/RhD blood group matching is considered an important factor in hematopoietic stem cell transplantation (HSCT) since ABO incompatibility may affect the engraftment and/or ABO expressed on recipient endothelial cells may represent targets for graft versus host disease. The CCR5 deletion (CCR5Δ32) is associated with HIV resistance and provides a therapeutic strategy for eradicating HIV infection in HIV+ patients undergoing HSCT. Currently, HLA typing of NMDP donors is performed on DNA isolated from buccal swabs. The goal of this study was to develop molecular typing methods for ABO/RhD and CCR5Δ32 for HSCT registry donors. 96 reference buccal swab samples were obtained from NMDP. The SSP typing for ABO/RhD and CCR5Δ32 were performed using a multiplex PCR (One Lambda) and the sizes of the amplicons were detected on 3730xl DNA Analyzer and interpreted with Gene Mapper 5. ABO typing was performed by NGS using in-house primers on Illumina MiSeq system and the results were analyzed using Galaxy (UCLA). For ABO blood group typing, both SSP and NGS typing methods yielded 100% concordance with reference in all major blood groups (A = 29.2%, B = 20.8%, AB = 20.8%, O = 29.2% respectively) and differentiated A1 and A2 subtypes. NGS typing identified a total of 4 A alleles, 1 B allele, and 10 O alleles with 7 novel mutations. Two mutations occurred in B101 (A930G) and O02 (G1105A). We discerned 7 O alleles without the nt261G deletion which included 5 O03 and 2 O49 alleles. O03 and O49 alleles have G802A compared to A101 which presumably inactivates the enzyme by altering its sugar-binging sites. In addition, the G1096A novel mutation was detected in all 5 O03 alleles. 100% concordance was achieved for RhD typing with 23 (24%) RhD- homozygous samples detected. In this cohort, no CCR5Δ32 double deletion was detected, but 13 CCR5Δ32/CCR5 heterozygous were found (13.5%). The CCR5Δ32 typing was confirmed by in-house SSP with 100% concordance. We demonstrate the ability to perform accurate molecular tying of blood group ABO/RhD and CCR5Δ32. Successful molecular typing of registry donors for ABO/RhD and CCR5Δ32 may reduce donor search time and time to transplant. In addition, the ability to identify novel/rare alleles can fill in gaps in knowledge of the existing blood antigen registry and further improve the HSCT outcome.

Identification of 12 Novel RHD Alleles in Western France by Denaturing High-Performance Liquid Chromatography Analysis.

Characterization of Novel RHD Allele Variants and Their Implications for Routine Blood Group Diagnostics

Estimating the serological underrecognition of patients with weak or partial RHD variants

Molecular and Family Analyses of a Novel RHD1058G>C Allele in a Chinese RhD Population

A Bioinformatically Initiated Approach to Evaluate GATA1 Regulatory Regions in Samples with Weak D, Del, or D- Phenotypes Despite Normal RHD Exons

Molecular Basis of ABO Variants Including Identification of 16 Novel ABO Subgroup Alleles in Chinese Han Population

Resolution of RHCE Haplotype Ambiguities in Transfusion Settings

Prediction of the antigenic regions in eight RhD variants identified by computational biology

A Chinese individual with DEL phenotype caused by a novel RHD allele.

Molecular basis of DEL phenotype in the Indian population - Insights from Next-Generation Sequencing Analysis of two cases

A DEL phenotype attributed to RHD Exon 9 sequence deletion: slipped-strand mispairing and blood group polymorphisms

A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system

Integrated analyses reveal unexpected complex inversion and recombination in RH genes

Genetic profile of RHCE, Kell, Duffy, Kidd, Diego and MNS hybrid glycophorins blood groups in ethnic northeastern Thais: Alleles, genotypes and risk of alloimmunisation

The Variation of RhD Blood Group in Different Periods in a Patient with Systemic Lupus Erythematosus

Aweak phenotype associated with novel ABO*A allele variant c.106delinsGG

The novel alleles, HLA‐G01:04:09 and HLA‐DPB104:01:01:136, detected in a hematopoietic cell donor

OR28 Advances in Molecular Typing of Abo/rhd and Ccr5δ32 Mutation

Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D- pregnant women

[Sequence analysis and identification of a novel HLA-DPB1*02:01:69 allele by third-generation sequencing]

Novel HLA-DQB1, DQA1, DPA1 and DPB1 alleles identified in the Australian new south wales tissue typing laboratory